Manufacturing Partnerships: Don’t Underestimate the Importance of Collaboration

Manufacturing Partnerships: Don’t Underestimate the Importance of Collaboration   Tim Hirst, CEO of GPN Vaccines, recently spoke with Outsourced Pharma about how BioCina quickly developed a new manufacturing process for their groundbreaking pneumococcal vaccine. Read the article in Outsourced Pharma: Click here  When selecting a CDMO, the most important traits to consider are speed, collaboration, and […]

Plasmid DNA Manufacturing- Insights from BioProcess International 2022

The widespread use of pDNA in cell and gene therapy (CGT) is driving increasing demand—and it’s no surprise it was one of the hottest topics at recent events including the recent BioProcess International (BPI) conference, what’s known as the largest bioprocessing event in the world.  Sessions covering topics as diverse as cell and gene therapy, […]

BioCina: Developing technologies to support the next generation of mRNA-based therapies

June 1, 2022 Published on Success Stories austrade.gov.au Australian biologics manufacturer BioCina has plans to further develop its state-of-the-art facility to enable it to make the next generation of mRNA vaccines and other mRNA-based therapies possible. Backed by Australian Government financial support, BioCina is partnering with the University of Adelaide and US-based Cytiva to speed […]

Behind the doors of the bacterial factory

Published in Cosmos Magazine By Ellen Phiddian Excerpts copied below. Read the full article in Cosmos Magazine at the link at the bottom of the page. BioCina’s pharmaceutical manufacturing plant, in Adelaide, is Australia’s only internationally certified microbial fermentation operation – and a lesson in keeping it clean. So how do they do it? Cosmos […]

Home-grown mRNA: inside the Adelaide facility that can make it

Published in Cosmos Magazine Excerpts copied below. Read the full article in Cosmos Magazine at the link at the bottom of the page. Cosmos takes a look at BioCina’s pharmaceutical manufacturing process. While Moderna has announced it will be making mRNA vaccines on Australian shores by 2024, there are places that could already be doing parts of […]

South Australian mRNA vaccines?

July 5, 2021 Published in Cosmos Magazine Excerpts copied below. Read the full article in Cosmos Magazine at the link at the bottom of the page. “Last month, the federal government closed applications for a critical approach to market process: it was looking for biotech firms that want to make messenger RNA (mRNA) vaccines in Australia. The […]

SA ‘well-heeled’ to manufacture advanced COVID vaccines

July 5, 2021 Published in InDaily Excerpts copied below. Read the full article in InDaily at the link at the bottom of the page. “A push to manufacture advanced mRNA coronavirus vaccines at a plant in Thebarton remains on track as biotech and research consortiums across Australia look to answer the Federal Government’s call to […]

SA in vaccine manufacturing race

May 14, 2021 Published in InDaily Excerpts copied below. Read the full article in InDaily at the link at the bottom of the page. “The race to secure COVID-19 vaccine manufacturing in South Australia is heating up as the federal government prepares to make an approach to market for a local mRNA manufacturing plant in […]

Proposal for SA manufacturing facility to mass produce Pfizer and Moderna vaccines

May 12, 2021 Published in NT News, by Emily Cosenza Excerpts copied below. Read the full article in NT News at the link at the bottom of the page. “Much needed Pfizer and Moderna vaccines to better protect Australians from COVID-19 could be developed in South Australia. A locally advanced manufacturing facility in Thebarton, in […]

South Australian university reveals mRNA vaccine manufacturing plan

May 1, 2021 Published in Business Standard Excerpts copied below. Read the full article in Business Standard at the link at the bottom of the page. ‘“Australia could achieve vaccine self-reliance within half a year after the University of Adelaide (UA) revealed a plan to manufacture mRNA vaccines. The university on Wednesday announced a joint […]